1990-2020年全球、区域及国家其他肌肉骨骼疾病负担及2050年预测:2021年全球疾病负担研究系统分析
该研究基于2021年全球疾病负担研究,估算1990-2020年204个国家和地区的其他肌肉骨骼疾病患病率、死亡率与伤残损失寿命年,并预测至2050年。
核心结论
- 2020年其他肌肉骨骼疾病造成大量全球伤残损失寿命年。
- 在个体疾病和危险因素被更明确量化之前,针对该负担的政策应对仍面临挑战。
- 非致死性疾病负担估计的时间趋势和地理差异基于稀疏、低质量数据,不应过度解读。
研究设计与样本
- 采用2021年全球疾病负担研究方法,利用23个国家68个数据源,通过从肌肉骨骼疾病总病例中减去类风湿关节炎、骨关节炎、下背痛、颈痛和痛风病例来估算其他肌肉骨骼疾病患病率。
- 使用贝叶斯荟萃回归模型按年份、年龄、性别和地点估算患病率,并据此估算伤残损失寿命年。
- 利用生命登记数据估算归因死亡,并以社会人口指数为预测变量对1990-2020年患病率回归后乘以人口预测值来预测2050年患病率。
主要发现
- 全球其他肌肉骨骼疾病年龄标化患病率女性比男性高47.4%(44.9-49.4),且随年龄增长至65-69岁达峰值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 非致死性疾病负担估计的时间趋势和地理差异基于稀疏、低质量数据,不应过度解读。
- 在个体疾病和危险因素被更明确量化之前,政策应对该负担仍面临挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Musculoskeletal disorders include more than 150 different conditions affecting joints, muscles, bones, ligaments, tendons, and the spine. To capture all health loss from death and disability due to musculoskeletal disorders, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) includes a residual musculoskeletal category for conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain, and neck pain. This category is called other musculoskeletal disorders and includes, for example, systemic lupus erythematosus and spondylopathies. We provide updated estimates of the prevalence, mortality, and disability attributable to other musculoskeletal disorders and forecasted prevalence to 2050. METHODS: Prevalence of other musculoskeletal disorders was estimated in 204 countries and territories from 1990 to 2020 using data from 68 sources across 23 countries from which subtraction of cases of rheumatoid arthritis, osteoarthritis, low back pain, neck pain, and gout from the total number of cases of musculoskeletal disorders was possible. Data were analysed with Bayesian meta-regression models to estimate prevalence by year, age, sex, and location. Years lived with disability (YLDs) were estimated from prevalence and disability weights. Mortality attributed to other musculoskeletal disorders was estimated using vital registration data. Prevalence was forecast to 2050 by regressing prevalence estimates from 1990 to 2020 with Socio-demographic Index as a predictor, then multiplying by population forecasts. FINDINGS: Globally, 494 million (95% uncertainty interval 431-564) people had other musculoskeletal disorders in 2020, an increase of 123·4% (116·9-129·3) in total cases from 221 million (192-253) in 1990. Cases of other musculoskeletal disorders are projected to increase by 115% (107-124) from 2020 to 2050, to an estimated 1060 million (95% UI 964-1170) prevalent cases in 2050; most regions were projected to have at least a 50% increase in cases between 2020 and 2050. The global age-standardised prevalence of other musculoskeletal disorders was 47·4% (44·9-49·4) higher in females than in males and increased with age to a peak at 65-69 years in male and female sexes. In 2020, other musculoskeletal disorders was the sixth ranked cause of YLDs globally (42·7 million [29·4-60·0]) and was associated with 83 100 deaths (73 600-91 600). INTERPRETATION: Other musculoskeletal disorders were responsible for a large number of global YLDs in 2020. Until individual conditions and risk factors are more explicitly quantified, policy responses to this burden remain a challenge. Temporal trends and geographical differences in estimates of non-fatal disease burden should not be overinterpreted as they are based on sparse, low-quality data. FUNDING: Bill & Melinda Gates Foundation.
引用
- Global, regional, and national burden of other musculoskeletal disorders, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023. PMID: 37927903. doi:10.1016/S2665-9913(23)00232-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。